Black Diamond Therapeutics, Inc. (BDTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Black Diamond Therapeutics, Inc. (BDTX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

BDTX Income Statement

Black Diamond Therapeutics, Inc. (BDTX) annual income statement — 9-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	70M	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	27K	0	0	86K	0	0	0	86K	86K	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-27K	0	0	-86K	70M	0	0	-86K	-86K	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	-100.04%	-	-	0%	81495.35%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	12.06M	11.26M	17.61M	10.98M	13.33M	15.47M	18.27M	18.13M	22.04M	20.16M	20.86M	24.01M	20.03M	21.56M	21.85M	22.12M	23.17M	25.68M	26.08M	35.36M
OpEx % of Revenue	-	-	-	-	-	22.1%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	4.66M	4.26M	3.97M	3.54M	4.1M	4.96M	5.98M	5.22M	9.57M	6.7M	5.57M	7.86M	6.88M	6.81M	7.24M	6.28M	6.98M	7.89M	6.42M	7.74M
SG&A % of Revenue	-	-	-	-	-	7.09%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	7.39M	7M	6.3M	7.44M	9.32M	10.51M	12.3M	12.91M	12.47M	13.46M	15.29M	16.15M	13.15M	14.75M	14.61M	15.85M	16.2M	17.79M	19.66M	27.63M
R&D % of Revenue	-	-	-	-	-	15.01%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	1000K	0	-86K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-12.06M	-11.26M	-17.61M	-10.98M	-13.42M	54.53M	-18.27M	-18.13M	-22.13M	-20.25M	-20.86M	-24.01M	-20.03M	-21.56M	-21.85M	-22.12M	-23.17M	-25.68M	-26.08M	-35.36M
Operating Margin %	-	-	-	-	-	77.9%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	10.16%	-120.65%	3.64%	39.45%	39.36%	369.34%	12.37%	24.5%	-10.47%	6.1%	4.56%	-8.53%	13.55%	16.04%	16.21%	37.44%	33.25%	16.39%	-12.5%	-91.36%
EBITDA	-12.03M	-11.23M	-17.54M	-10.89M	-13.33M	54.62M	-18.19M	-18.04M	-22.04M	-20.16M	-20.77M	-23.9M	-19.92M	-21.44M	-21.73M	-22M	-23.05M	-25.55M	-25.96M	-35.32M
EBITDA Margin %	-	-	-	-	-	78.02%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	9.79%	-120.57%	3.55%	39.64%	39.51%	370.92%	12.42%	24.49%	-10.67%	5.97%	4.4%	-8.65%	13.57%	16.1%	16.3%	37.73%	33.58%	16.75%	-12.04%	-91.28%
D&A (Non-Cash Add-back)	28K	27K	66K	86K	86K	87K	85K	86K	86K	86K	86K	115K	114K	122K	126K	129K	128K	125K	123K	43K
EBIT	-13.29M	-9.04M	-10.26M	-8.5M	-10.56M	56.54M	-15.98M	-15.56M	-19.91M	-18.23M	-20.86M	-24.01M	-20.03M	-21.56M	-21.85M	-22.12M	-23.17M	-25.68M	-25.87M	-35.36M
Net Interest Income	922K	1.02M	1.18M	1.16M	1.12M	595K	565K	516K	464K	637K	324K	439K	539K	622K	677K	562K	386K	406K	588K	776K
Interest Income	922K	1.02M	1.18M	1.16M	1.12M	595K	565K	516K	464K	637K	324K	439K	539K	622K	677K	562K	386K	406K	588K	776K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	2.15M	2.22M	2.49M	2.48M	2.86M	2.01M	2.29M	2.57M	2.22M	2.02M	1.45M	1M	880K	686K	774K	470K	243K	172K	213K	287K
Pretax Income	-9.9M	-9.04M	-15.12M	-8.5M	-10.56M	56.54M	-15.98M	-15.56M	-19.91M	-18.23M	-19.41M	-23.01M	-19.15M	-20.88M	-21.08M	-21.65M	-22.93M	-25.51M	-25.87M	-35.08M
Pretax Margin %	-	-	-	-	-	80.77%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-9.9M	-9.04M	-15.12M	-8.5M	-10.56M	56.54M	-15.98M	-15.56M	-19.91M	-18.23M	-19.41M	-23.01M	-19.15M	-20.88M	-21.08M	-21.65M	-22.93M	-25.51M	-25.87M	-35.08M
Net Margin %	-	-	-	-	-	80.77%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	6.21%	-115.98%	5.44%	45.38%	46.95%	410.24%	17.64%	32.38%	-3.95%	12.69%	7.92%	-6.25%	16.48%	18.16%	18.51%	38.27%	33.25%	15.82%	-14.32%	-95.83%
Net Income (Continuing)	-9.9M	-9.04M	-15.12M	-8.5M	-10.56M	56.54M	-15.98M	-15.56M	-19.91M	-18.23M	-19.41M	-23.01M	-19.15M	-20.88M	-21.08M	-21.65M	-22.93M	-25.51M	-25.87M	-35.08M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.17	-0.16	-0.26	-0.15	-0.19	0.98	-0.28	-0.28	-0.36	-0.35	-0.41	-0.45	-0.52	-0.57	-0.59	-0.60	-0.63	-0.70	-0.71	-0.97
EPS Growth %	10.53%	-116.33%	7.14%	46.43%	47.22%	380%	31.71%	37.78%	30.77%	38.6%	30.51%	25%	17.46%	18.57%	16.9%	38.14%	33.68%	16.67%	-12.7%	-94%
EPS (Basic)	-0.17	-0.16	-0.26	-0.15	-0.19	1.00	-0.28	-0.28	-0.36	-0.35	-0.41	-0.45	-0.52	-0.57	-0.59	-0.60	-0.63	-0.70	-0.71	-0.97
Diluted Shares Outstanding	57.37M	57.23M	57.09M	56.93M	56.8M	57.67M	56.61M	56.51M	55.16M	51.81M	47.45M	50.94M	36.52M	36.48M	36.39M	36.35M	36.29M	36.27M	36.23M	36.22M
Basic Shares Outstanding	57.37M	57.23M	57.09M	56.65M	56.8M	56.66M	56.61M	56.51M	55.16M	51.81M	47.45M	50.94M	36.52M	36.48M	36.39M	36.35M	36.29M	36.27M	36.23M	36.22M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-